Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 3
2019 5
2020 9
2021 10
2022 13
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma.
Malard F, Battipaglia G, Gaugler B, Siblany L, van de Wyngaert Z, Bonnin A, Duléry R, Banet A, Stocker N, Ricard L, Brissot E, Mohty M. Malard F, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Nov;58(11):1275-1278. doi: 10.1038/s41409-023-02078-1. Epub 2023 Aug 22. Bone Marrow Transplant. 2023. PMID: 37608072 No abstract available.
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation.
Duléry R, Malard F, Brissot E, Banet A, Sestili S, Belhocine R, Calabro M, Van de Wyngaert Z, Bonnin A, Ledraa T, Legrand O, Labopin M, Capderou E, Cohen A, Ederhy S, Mohty M. Duléry R, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Nov;58(11):1215-1222. doi: 10.1038/s41409-023-02085-2. Epub 2023 Aug 18. Bone Marrow Transplant. 2023. PMID: 37596473
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Talbot A, Bobin A, Tabone L, Lambert J, Boccaccio C, Deal C, Petillon MO, Allangba O, Agape P, Arnautou P, Belkhir R, Cailleres S, Chaoui D, Chrétien ML, Decaux O, Schulmann S, Frenzel L, Gastaud L, Huart A, Hulin C, Karlin L, Laribi K, Le Calloch R, Lenain P, Macro M, Manier S, Montes L, Moreau S, Moreau P, Morel V, Norwood J, Piocelle FO, Perrot A, Pica GM, Rey P, Schmitt A, Stoppa AM, Tiab M, Touzeau C, Vidal V, Vignon M, Vincent L, Van De Wyngaert Z, Zarnitsky C, Kerbouche N, Paka P, Leleu X, Arnulf B, Avet-Loiseau H, Du Myélome IIF. Talbot A, et al. Among authors: van de wyngaert z. Haematologica. 2023 Oct 1;108(10):2774-2782. doi: 10.3324/haematol.2022.281772. Haematologica. 2023. PMID: 37078253 Free PMC article.
Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03).
van de Wyngaert Z, Malard F, Hulin C, Caillot D, Mariette C, Facon T, Touzeau C, Perrot A, Moreau P, Hebraud B, Kanouni T, Heshmati F, Lebon D, Mohty M, Chabannon C. van de Wyngaert Z, et al. Clin Hematol Int. 2023 Mar;5(1):38-42. doi: 10.1007/s44228-023-00030-0. Epub 2023 Feb 12. Clin Hematol Int. 2023. PMID: 36781774 Free PMC article.
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Duléry R, Goudet C, Mannina D, Bianchessi A, Granata A, Harbi S, Maisano V, Chabannon C, Malard F, Brissot E, Sestili S, Banet A, Van de Wyngaert Z, Belhocine R, Ederhy S, Castagna L, Bramanti S, Blaise D, Mohty M, Fürst S, Devillier R. Duléry R, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Apr;58(4):386-392. doi: 10.1038/s41409-022-01908-y. Epub 2022 Dec 30. Bone Marrow Transplant. 2023. PMID: 36585459
Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases.
Otiniano A, van de Wyngaert Z, Brissot E, Dulery R, Gozlan J, Daguenel A, Abi Aad Y, Ricard L, Stocker N, Banet A, Bonnin A, Alsuliman T, Marjanovic Z, Schnuriger A, Coppo P, Legrand O, Lacombe K, Mohty M, Malard F. Otiniano A, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Mar;58(3):340-342. doi: 10.1038/s41409-022-01894-1. Epub 2022 Dec 8. Bone Marrow Transplant. 2023. PMID: 36481838 Free PMC article. No abstract available.
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation.
Banet A, Bazarbachi A, Labopin M, Stocker N, Duléry R, Malard F, Van de Wyngaert Z, Genthon A, Memoli M, Legrand O, Bonnin A, Ledraa T, Belhocine R, Sestili S, El-Cheikh J, Mohty M, Brissot E. Banet A, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Jan;58(1):61-67. doi: 10.1038/s41409-022-01841-0. Epub 2022 Oct 12. Bone Marrow Transplant. 2023. PMID: 36224494
Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation.
Stocker N, Baltes V, Bellaiche S, Brouillard F, Belmoufid N, Rousseau C, Bonnin A, Van de Wyngaert Z, Ricard L, Banet A, Malard F, Duléry R, Mohty M, Brissot E. Stocker N, et al. Among authors: van de wyngaert z. Support Care Cancer. 2022 Oct;30(10):8211-8216. doi: 10.1007/s00520-022-07280-3. Epub 2022 Jul 9. Support Care Cancer. 2022. PMID: 35810217
Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak.
Kohn M, Alsuliman T, Lamure S, Cheminant M, Delage J, Merle De Boever C, Tudesq JJ, Marjanovic Z, Van de Wyngaert Z, Malard F, Brissot E, Rigaudeau S, Marque-Juillet S, Therby A, Cartron G, Rousselot P, Hermine O, Duléry R, Besson C. Kohn M, et al. Among authors: van de wyngaert z. Leuk Lymphoma. 2022 Nov;63(11):2686-2690. doi: 10.1080/10428194.2022.2086249. Epub 2022 Jun 18. Leuk Lymphoma. 2022. PMID: 35719107 No abstract available.
38 results